The meeting unites professionals engaged in the practice and study of medical laboratory immunology and provides an opportunity to enhance their knowledge of immunologic principles and their application to immune mediated disorders, infectious disease, cancer, and quality assurance/quality control of immunologic testing. Attendees will hear experts in the field present new and cutting-edge information about the pathogenesis, diagnosis, monitoring and treatment of these disorders. This meeting will also highlight new discoveries in immunology and novel and emerging technologies in laboratory medicine. Finally, this annual meeting offers the individual not only a format for learning but also for collaborations and essential interactions vital to their development and growth.
After attending the meeting attendees should be able to:
- Discuss the application and interpretation of various methods for the detection of antinuclear autoantibodies.
- Discuss the appropriate testing and interpretation of the test results with development of a differential diagnosis for five selected cases.
- Discuss cutting edge diagnostic approaches for infectious diseases including systemic fungal infections, Influenza, and HIV
- Describe a new paradigm for laboratory accreditation (CAP15189) and approaches for assessing and enhancing laboratory quality and efficiency.
- Discuss new developments in the treatment of cancer and autoimmune diseases using cytokine-specific targeting.
- Discuss the application of autoantibody detection for Type 1 Diabetes
- Discuss the status of cancer vaccines.
- Discuss the significance of circulating tumor cell detection in cancer patients.
Faculty and all others who have the ability to control the content of continuing medical education activities sponsored by the AMLI are expected to disclose to the audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentations.